半胱氨酸蛋白酶抑制剂B(CSTB)多克隆抗体(异硫氰酸荧光素标记)
FITC-Linked Polyclonal Antibody to Cystatin B (CSTB)
Cys-B; CST6; EPM1; PME; STFB; CPI-B; Stefin B; Liver thiol proteinase inhibitor
- 编号LAJ322Bo81
- 物种Bos taurus; Bovine (Cattle,牛) 相同的名称,不同的物种。
- 来源抗体标记
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物荧光素
- 原抗体 -
- 缓冲液成份磷酸盐缓冲液(pH7.4,含有0.02% NaN3和50%甘油)
- 性状液体
- 浓度500µg/mL
- 且适物种-
- 应用WB; IHC; ICC; IF.
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 1058 ¥ 2470 ¥ 3528 ¥ 8820 ¥ 35280
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
该抗体是针对CSTB的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别CSTB。
用法
免疫印迹:0.2-2µg/mL;1:250-2500
免疫组织化学:5-20µg/mL;1:25-100
免疫细胞化学:5-20µg/mL;1:25-100
最佳稀释倍数最终由用户决定。
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
增值服务
相关产品
编号 | 适用物种:Bos taurus; Bovine (Cattle,牛) | 应用(仅供研究使用,不用于临床诊断!) |
RPJ322Bo01 | 半胱氨酸蛋白酶抑制剂B(CSTB)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAJ322Bo01 | 半胱氨酸蛋白酶抑制剂B(CSTB)多克隆抗体 | WB; IHC; ICC; IP. |
LAJ322Bo81 | 半胱氨酸蛋白酶抑制剂B(CSTB)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
LAJ322Bo71 | 半胱氨酸蛋白酶抑制剂B(CSTB)多克隆抗体(生物素标记) | WB; IHC; ICC. |
参考文献
杂志 | 参考文献 |
AIDS. | Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders [PubMed: 23291538] |
International Journal of Circumpolar Health | Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer [PubMed: PMC3754495] |
PLoS One. | Dysregulation of Macrophage-Secreted Cathepsin B Contributes to HIV-1-Linked Neuronal Apoptosis [PubMed: PMC3365072] |
Journal of Neuroimmune Pharmacology | Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages [Pubmed:25209871] |
European Journal of Cancer Supplements | A91: Endogenous inhibitors of cysteine proteases and preform of cathepsin B in cancer of reproductive system [Science: Article] |
Annals of Clinical Biochemistry | Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis. [pubmed:28766361] |
留言咨询